Filing Flows › biote (BTMD) › Capital expenditures
biote (BTMD) capital expenditures by quarter
biote's capital expenditures were $2.6M in Q3 2026 (third quarter 2026), +612% from Q1 2026. Over the last 6 quarters it ranged from $362K (Q1 2026) to $2.6M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.6M | +612% | +416% |
| Q1 2026 | $362K | -66% | -78% |
| Q4 2025 | $1.1M | +116% | — |
| Q3 2025 | $499K | -72% | — |
| Q2 2025 | $1.8M | +11% | — |
| Q1 2025 | $1.6M | — | — |
Q3 2026 at a glance
biote, Q3 2026: revenue $43.3M (-10% year over year), operating margin 5.7%, net earnings $407K, operating cash flow $3.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is biote's capital expenditures?
biote's capital expenditures were $2.6M in Q3 2026 (third quarter 2026), +612% from Q1 2026.
How has biote's capital expenditures changed?
Over the last 6 quarters it ranged from $362K (Q1 2026) to $2.6M (Q3 2026).